WHIP-131

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameWHIP-131
Drug Alias NameWHI-P131DDE-9501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsApoptosis stimulantsCollagen inhibitors +[4] 
TargetsTyrosine-protein kinase JAK3Collagen
Therapy Area/IndicationsAllergic asthmaGraft vs Host DiseaseSkin Diseases +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWayne Hughes Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWayne Hughes Institute
Active IndicationsN/A
Inactive IndicationsAllergic asthmaGraft vs Host DiseaseSkin Diseases +[7] 

Other Information

ATC CodeN/A
Related LinksN/A